A Phase 1, Open-Label, Single Oral Dose Study to Assess the Safety, Pharmacokinetics and Effect of Food on the Pharmacokinetics of Mirabegron (YM178) in Healthy Volunteers.

Trial Profile

A Phase 1, Open-Label, Single Oral Dose Study to Assess the Safety, Pharmacokinetics and Effect of Food on the Pharmacokinetics of Mirabegron (YM178) in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Oct 2011

At a glance

  • Drugs Mirabegron (Primary)
  • Indications Overactive bladder
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Oct 2011 Actual end date (June 2011) added as reported by ClinicalTrials.gov.
    • 11 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top